Skip to main content
Nureca Limited logo

Nureca Limited — Investor Relations & Filings

Ticker · NURECA ISIN · INE0DSF01015 LEI · 894500NRGNYR07CDBN26 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 302 across all filing types
Latest filing 2023-11-04 Investor Presentation
Country IN India
Listing BSE.NS NURECA

About Nureca Limited

https://www.nureca.com

Nureca Limited specializes in the development and distribution of home healthcare devices and lifestyle products. The company operates through several key brands, most notably Dr Trust, Dr Physio, and Trumom. Its product portfolio includes medical diagnostic tools such as blood pressure monitors, pulse oximeters, nebulizers, and thermometers, as well as wellness equipment like massagers and personal scales. Nureca utilizes a digital-first business model, prioritizing e-commerce channels to provide consumers with accessible medical technology. The company focuses on integrating clinical-grade accuracy with user-centric design to support chronic disease management, fitness tracking, and maternal care. By offering a diverse range of health monitoring solutions, Nureca aims to empower individuals to manage their well-being through proactive and data-driven home-based care.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is explicitly described as such in the text. It references financial performance for the second quarter and half year ended September 30, 2023, and includes detailed financial highlights, strategic pillars, product information, and growth metrics. The document is about 15,000 characters long, which is substantial and contains detailed financial and strategic information. It is not a brief announcement or a certification, nor is it a full annual or interim report with formal financial statements. The content aligns with a presentation aimed at investors summarizing financial results and company strategy. Therefore, the document fits the category of an Investor Presentation (IP).
2023-11-04 English
Financial Result Updates
Regulatory Filings
2023-11-04 English
Board Meeting — NURECA LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Y…
Regulatory Filings
2023-10-28 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled for November 4, 2023, where the company will consider and approve unaudited financial results for the quarter and half year ended September 30, 2023. It is a regulatory announcement pursuant to SEBI Listing Obligations and Disclosure Requirements. The document does not contain any financial data or results itself, nor does it include detailed financial analysis or reports. It is essentially an announcement of a future event (Board Meeting) related to financial results approval. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit into more specific categories like Interim Report or Earnings Release, which would require actual financial data or results.
2023-10-28 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice from Nureca Limited informing stock exchanges about the closure of the trading window in compliance with insider trading regulations. It specifies the trading window closure period related to the upcoming unaudited financial results for the quarter and half year ended September 30, 2023. The document does not contain any financial data, results, or detailed report content. It is a regulatory announcement about trading restrictions rather than a financial report or earnings release. The document length is short (1518 characters), and it serves as a notification to exchanges rather than a report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-09-30 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of the Chief Financial Officer (CFO) of Nureca Limited. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about a management personnel change, specifically the resignation of a key managerial person. The document length is short (2167 characters) and it does not contain financial data or detailed reports. Therefore, it is not an annual report, earnings release, or any financial report. It is an announcement of a change in senior management, fitting the category of Board/Management Information (MANG).
2023-09-07 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.